AI-Powered Pharmaceutical Documentation: Transforming Manual PIL Creation into Automated Compliance
- React
- Python
- Azure Microsoft
- PostgreSQL
- Flowise
EXPERTISES
Project Context
Solution
Outcome
About Client
Our client is a mid-sized pharmaceutical company based in Europe, specializing in developing and marketing prescription medications.
Like many forward-thinking organizations in the pharmaceutical sector, they are actively pursuing digital transformation initiatives to streamline their operations and maintain competitive advantage in an increasingly fast-paced regulatory environment.
Business challenge
The pharmaceutical industry operates under some of the strictest regulatory requirements globally, and creating compliant documentation is both critical and complex.
Our client faced a significant operational bottleneck: the manual process of creating EU-compliant patient information leaflets (PILs) based on general drug information was consuming 2-3 weeks per product. Through our analysis, we determined that these PILs could be efficiently generated directly from Summary of Product Characteristics (SmPC) documents.
This manual approach created multiple pain points:
- Time-intensive process that delayed product launches and market entry
- Usual risk of human error in a zero-tolerance regulatory environment, with critical items being overlooked even in seemingly straightforward documents – something that happens to the best of us, even with the simplest leaflets
- Deep regulatory expertise and knowledge of the product (drug) context required for every document, creating resource constraints
- Inconsistency challenges when scaling across drugs in the one product family simultaneously
- Iterative reviews adding layers of complexity and extending timelines
- Opportunity cost as regulatory teams spent valuable time on repetitive tasks instead of strategic initiatives
With strict regulatory deadlines and the need to launch multiple products simultaneously, the client was struggling to maintain accuracy and consistency while meeting critical market timelines.
In today's competitive pharmaceutical landscape, delays in documentation can translate directly into lost revenue and market opportunities.
Approach
Understanding the complexity and regulatory sensitivity of pharmaceutical documentation, we designed a tailored approach specifically for this challenge:
Team Assembly & Expertise Matching
We carefully selected specialists who underwent rigorous external and internal interviews, ensuring deep expertise in both AI/ML technologies and pharmaceutical regulatory requirements. Our team included professionals with proven track records in RegTech solutions.
Structured Project Framework
We identified key phases for addressing the challenge:
- Discovery and regulatory compliance analysis
- Rule-based logic development with iterative refinement
- Human-in-the-Loop (HITL) validation cycles
- Proof of Concept delivery and testing
Collaborative Discovery Process
We established additional clarification meetings with the client's regulatory affairs team and subject matter experts to ensure complete understanding of EU compliance requirements and internal processes of pharmaceutical companies..
Problem Framing & Execution Setup
After thoroughly analyzing the regulatory landscape and client needs, we framed the challenge as an AI-powered automation solution enhanced by pharmaceutical domain expertise. We structured a dedicated team and initiated the project with clear compliance and accuracy objectives.
The project followed our proven delivery methodology, transitioning seamlessly into a maintenance phase where Binariks continues to provide ongoing support and potential enhancements.
Implementation
Our technical solution leveraged cutting-edge AI capabilities while maintaining the precision required for pharmaceutical regulatory compliance:
Core Architecture
We developed a Proof of Concept tool using Microsoft Copilot as the AI foundation, enhanced with sophisticated rule-based logic specifically designed for EU pharmaceutical regulations. The solution architecture includes:
- Document processing engine: Automated SmPC document ingestion and parsing
- Rule-based transformation logic: Iteratively refined rules ensuring EU compliance standards according to the guidelines
- AI-enhanced content generation: Leveraging Copilot's language capabilities while maintaining regulatory precision
- Human-in-the-loop validation: Built-in review cycles conducted by subject matter experts
- Compliance verification: Automated checks against EU pharmaceutical leaflet requirements
Key Technical Components
- Input processing: Seamless upload and analysis of SmPC documents in various formats
- Intelligent extraction: AI-powered identification of key pharmaceutical information sections
- Regulatory mapping: Automated conversion following EU-specific leaflet structure requirements
- Quality assurance: Multi-layer validation ensuring accuracy and compliance
- Output generation: Production of compliant EU patient information leaflets
Scalability Foundation
The solution backbone is designed to support future enhancements, including:
- Additional pharmaceutical document types (SPL to MedGuide for US market)
- Multi-regional compliance adaptations
- Automated translation capabilities
- Integration with existing pharmaceutical management systems
Technology Stack
- AI platform: Copilot for advanced language processing
- Development approach: Agile methodology with continuous feedback integration
- Validation framework: Human-in-the-Loop collaboration with pharmaceutical SMEs
Value Delivered
The project successfully addressed all identified challenges while delivering measurable improvements in efficiency, accuracy, and compliance.
- Dramatic time and cost reduction: Manual PIL creation dropped from 2-3 weeks to 1-2 days for review and approval – an 85% reduction in processing time that significantly lowered operational expenses and accelerated market entry.
- Enhanced accuracy and consistency: AI-driven, rule-based content mapping precisely converts SmPC information into patient-friendly PIL sections, reducing human errors and maintaining consistency across all documentation – critical in zero-tolerance regulatory environments.
- Regulatory compliance achievement: All generated PILs adhere to EU regulatory standards for content, formatting, and readability, ensuring full compliance with Directive 2001/83/EC. Automated compliance verification eliminates regulatory rejection risks.
- Scalable operations: The client now manages multiple product launches simultaneously without previous resource constraints. The automated solution scales effortlessly across product portfolios, enabling faster market entry and competitive advantage.
Additional value discovered:
- Strategic resource reallocation: Regulatory teams focus on strategic initiatives instead of repetitive documentation
- Process standardization: Consistent methodology ensures uniform quality and compliance
- Future-ready foundation: Architecture supports expansion to additional document types and regulatory regions
More case studies
Web and Mobile solution for meditation
Binariks developed a mobile and web meditation app for Spanish-speaking users. We provided software development and QA services to launch a demand on the market product.
Software Development and Design Services for Food Marketplace
Binariks facilitated an American food delivery business by optimizing their web and mobile platforms, providing UI/UX services, and ensuring QA testing.
Secure Messaging Platform Based on ID Authentication
Binariks helped a Swedish technology company in developing a secure messaging platform based on the national BankID authentication.
